| Record Information |
|---|
| Version | 1.0 |
|---|
| Creation Date | 2016-05-25 18:26:33 UTC |
|---|
| Update Date | 2016-11-09 01:17:27 UTC |
|---|
| Accession Number | CHEM022276 |
|---|
| Identification |
|---|
| Common Name | Dihydroergotoxine |
|---|
| Class | Small Molecule |
|---|
| Description | |
|---|
| Contaminant Sources | - HMDB Contaminants - Urine
|
|---|
| Contaminant Type | Not Available |
|---|
| Chemical Structure | |
|---|
| Synonyms | | Value | Source |
|---|
| CO-Dergocrine | MeSH | | Alkaloids, hydrogenated ergot | MeSH | | Dihydroergotoxin | MeSH | | Ergot alkaloids, hydrogenated | MeSH | | Hydrogenated ergot alkaloids | MeSH | | Angionorm | MeSH | | D Tamin retard l.u.t. | MeSH | | D.H.E. 45 | MeSH | | DHE 45 | MeSH | | DHE ratiopharm | MeSH | | DHE-puren | MeSH | | Dihydroergotamine-sandoz | MeSH | | Ergomimet | MeSH | | Orstanorm | MeSH | | Seglor | MeSH | | DET MS | MeSH | | DHE puren | MeSH | | DHE45 | MeSH | | Dihydroergotamine methanesulfonate | MeSH | | Ergont | MeSH | | Hormosan brand OF dihydroergotamine mesylate | MeSH | | Ikaran | MeSH | | Pharmafrid brand OF dihydroergotamine mesylate | MeSH | | Q-Pharm brand OF dihydroergotamine mesylate | MeSH | | Sanol brand OF dihydroergotamine mesylate | MeSH | | Schwarz brand OF dihydroergotamine mesylate | MeSH | | Verla brand OF dihydroergotamine mesylate | MeSH | | Xcel brand 1 OF dihydroergotamine mesylate | MeSH | | Ergotam von CT | MeSH | | Agit | MeSH | | Aliud brand OF dihydroergotamine mesylate | MeSH | | D-Tamin retard l.u.t. | MeSH | | DHE-45 | MeSH | | DHE-ratiopharm | MeSH | | Dihydergot | MeSH | | Dihydroergotamin al | MeSH | | Dihydroergotamine | MeSH | | Dihydroergotamine sandoz | MeSH | | Dihytamin | MeSH | | Erganton | MeSH | | Farmasan brand OF dihydroergotamine mesylate | MeSH | | Fujisawa brand OF dihydroergotamine mesylate | MeSH | | Mesylate, dihydroergotamine | MeSH | | Novartis brand OF dihydroergotamine mesylate | MeSH | | Q Pharm brand OF dihydroergotamine mesylate | MeSH | | Shire brand OF dihydroergotamine mesylate | MeSH | | Tamik | MeSH | | Verladyn | MeSH | | Ratiopharm brand OF dihydroergotamine mesylate | MeSH | | Alpharma brand OF dihydroergotamine mesylate | MeSH | | anto Brand OF dihydroergotamine mesylate | MeSH | | Clavigrenin | MeSH | | Desitin brand OF dihydroergotamine mesylate | MeSH | | IPRAD brand OF dihydroergotamine mesylate | MeSH | | Methanesulfonate, dihydroergotamine | MeSH | | Migranal | MeSH | | Pierre fabre brand OF dihydroergotamine mesylate | MeSH | | Wernigeroide brand OF dihydroergotamine mesylate | MeSH | | Xcel brand 2 OF dihydroergotamine mesylate | MeSH | | CT Arzneimittel brand OF dihydroergotamine mesylate | MeSH | | CT-Arzneimittel brand OF dihydroergotamine mesylate | MeSH | | Dihydroergotoxine | MeSH | | Dihydroergotamine mesylic acid | Generator | | Von CT, ergotam | MeSH | | (4R,7R)-N-[(1S,2S,4R,7S)-7-Benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0²,⁶]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraene-4-carboximidate | | | methanesulfonate | | | methanesulphonate | | | (4R,7R)-N-[(1S,2S,4R,7S)-7-Benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0²,⁶]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraene-4-carboximidic acid | | | methanesulphonic acid | |
|
|---|
| Chemical Formula | C34H41N5O8S |
|---|
| Average Molecular Mass | 679.783 g/mol |
|---|
| Monoisotopic Mass | 679.268 g/mol |
|---|
| CAS Registry Number | 11032-41-0 |
|---|
| IUPAC Name | (4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0²,⁶]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraene-4-carboxamide; methanesulfonic acid |
|---|
| Traditional Name | (4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0²,⁶]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraene-4-carboxamide; methanesulfonic acid |
|---|
| SMILES | CS(O)(=O)=O.[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@@H]3CC4C5=C6C(C[C@@]4([H])N(C)C3)=CNC6=CC=C5)O[C@@]21O |
|---|
| InChI Identifier | InChI=1S/C33H37N5O5.CH4O3S/c1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32;1-5(2,3)4/h3-6,8-11,17,21,23,25-27,34,42H,7,12-16,18H2,1-2H3,(H,35,39);1H3,(H,2,3,4)/t21-,23?,25-,26+,27+,32-,33+;/m1./s1 |
|---|
| InChI Key | ADYPXRFPBQGGAH-WVVAGBSPSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | belongs to the class of organic compounds known as ergotamines, dihydroergotamines, and derivatives. These are organic compounds containing an ergotamine moiety, which is structurally characterized by a benzyl substituent attached to the piperazine ring of the ergopeptine backbone. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Alkaloids and derivatives |
|---|
| Class | Ergoline and derivatives |
|---|
| Sub Class | Lysergic acids and derivatives |
|---|
| Direct Parent | Ergotamines, dihydroergotamines, and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Dihydroergotamine
- Ergotamine
- Hybrid peptide
- Alpha-dipeptide
- Lysergic acid amide
- Indoloquinoline
- Benzoquinoline
- Quinoline-3-carboxamide
- N-acyl-alpha amino acid or derivatives
- Pyrroloquinoline
- Alpha-amino acid or derivatives
- Quinoline
- 3-alkylindole
- Indole
- Indole or derivatives
- Isoindole or derivatives
- Piperidinecarboxamide
- 3-piperidinecarboxamide
- Aralkylamine
- N-alkylpiperazine
- Benzenoid
- Monocyclic benzene moiety
- 1,4-diazinane
- Oxazolidinone
- Piperazine
- Piperidine
- Tertiary carboxylic acid amide
- Heteroaromatic compound
- Oxazolidine
- Pyrrolidine
- Pyrrole
- Amino acid or derivatives
- Lactam
- Tertiary aliphatic amine
- Secondary carboxylic acid amide
- Orthocarboxylic acid derivative
- Carboxamide group
- Tertiary amine
- Oxacycle
- Organoheterocyclic compound
- Azacycle
- Alkanolamine
- Carboxylic acid derivative
- Organonitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Carbonyl group
- Organic nitrogen compound
- Amine
- Organooxygen compound
- Organic oxide
- Hydrocarbon derivative
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Not Available |
|---|
| External Descriptors | Not Available |
|---|
| Biological Properties |
|---|
| Status | Detected and Not Quantified |
|---|
| Origin | Not Available |
|---|
| Cellular Locations | Not Available |
|---|
| Biofluid Locations | Not Available |
|---|
| Tissue Locations | Not Available |
|---|
| Pathways | Not Available |
|---|
| Applications | Not Available |
|---|
| Biological Roles | Not Available |
|---|
| Chemical Roles | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Appearance | Not Available |
|---|
| Experimental Properties | | Property | Value |
|---|
| Melting Point | Not Available | | Boiling Point | Not Available | | Solubility | Not Available |
|
|---|
| Predicted Properties | |
|---|
| Spectra |
|---|
| Spectra | | Spectrum Type | Description | Splash Key | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (1 TMS) - 70eV, Positive | splash10-00di-9200000000-a6aedebec0989c761162 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-001i-0000009000-1ac4358ad4248c2aec50 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-001i-0000009000-1ac4358ad4248c2aec50 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-001i-0000009000-1ac4358ad4248c2aec50 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-004i-0000009000-a2905fea221f6d7714cd | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-004i-0000009000-a2905fea221f6d7714cd | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-004i-0000009000-a2905fea221f6d7714cd | Spectrum |
|
|---|
| Toxicity Profile |
|---|
| Route of Exposure | Not Available |
|---|
| Mechanism of Toxicity | Not Available |
|---|
| Metabolism | Not Available |
|---|
| Toxicity Values | Not Available |
|---|
| Lethal Dose | Not Available |
|---|
| Carcinogenicity (IARC Classification) | Not Available |
|---|
| Uses/Sources | Not Available |
|---|
| Minimum Risk Level | Not Available |
|---|
| Health Effects | Not Available |
|---|
| Symptoms | Not Available |
|---|
| Treatment | Not Available |
|---|
| Concentrations |
|---|
| Not Available |
|---|
| External Links |
|---|
| DrugBank ID | Not Available |
|---|
| HMDB ID | HMDB0015404 |
|---|
| FooDB ID | Not Available |
|---|
| Phenol Explorer ID | Not Available |
|---|
| KNApSAcK ID | Not Available |
|---|
| BiGG ID | Not Available |
|---|
| BioCyc ID | Not Available |
|---|
| METLIN ID | Not Available |
|---|
| PDB ID | Not Available |
|---|
| Wikipedia Link | Not Available |
|---|
| Chemspider ID | 4925595 |
|---|
| ChEBI ID | Not Available |
|---|
| PubChem Compound ID | 6420006 |
|---|
| Kegg Compound ID | Not Available |
|---|
| YMDB ID | Not Available |
|---|
| ECMDB ID | Not Available |
|---|
| References |
|---|
| Synthesis Reference | Not Available |
|---|
| MSDS | Not Available |
|---|
| General References | Not Available |
|---|